- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
GAMMA Investing LLC Increases Johnson & Johnson (JNJ) Holdings
Investment firm adds 7,245 shares to its portfolio of the healthcare giant's stock.
Mar. 21, 2026 at 8:07am
Got story updates? Submit your updates here. ›
GAMMA Investing LLC, a financial management firm, increased its holdings in Johnson & Johnson (NYSE:JNJ) by 13.3% during the fourth quarter, according to a recent SEC filing. The firm now owns 61,754 shares of the company's stock, valued at $12.78 million.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer products. Institutional investors closely monitor changes in ownership of blue-chip stocks like JNJ, as it can signal broader market trends and investor sentiment.
The details
GAMMA Investing LLC purchased an additional 7,245 shares of Johnson & Johnson stock during the fourth quarter, bringing its total position to 61,754 shares. This represents approximately 0.6% of the firm's total investment portfolio. Johnson & Johnson's stock has seen strong performance recently, closing at $235.64 per share on Friday.
- GAMMA Investing LLC increased its JNJ holdings during the 4th quarter of 2025.
The players
GAMMA Investing LLC
A financial management firm that increased its stake in Johnson & Johnson by 13.3% last quarter.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.
The takeaway
GAMMA Investing's increased position in Johnson & Johnson reflects ongoing investor confidence in the healthcare conglomerate's diversified business model and growth potential. As a bellwether stock, JNJ's performance is closely watched by the broader market.
